Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Join | Sign in

  News Archive

Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial
Friday, March 27, 2015
Liberia-U.S. partnership planning Phase 3 trial and study of Ebola survivors.

Novasep and Celladon Execute MYDICAR API Supply Agreement
Thursday, March 26, 2015
An innovative, genetically-targeted enzyme replacement therapy based on AAV1/SERCA2a.

Horizon and Partners Awarded Up to £6.2M Funding
Thursday, March 26, 2015
Horizon to receive up to £652,000 to expand bioproduction research.

Study Announces a Durable Vaccine for Ebola
Thursday, March 26, 2015
Researchers from Plymouth University have led team which has developed a durable vaccine for Ebola together with a disseminating vaccine strategy.

Valneva Announces Approval of an EB66®-based Prototype Influenza Vaccine in Japan
Thursday, March 26, 2015
The vaccine was developed by the Chemo-Sero Therapeutic Research Institute (Kaketsuken) in collaboration with GlaxoSmithKline using Valneva’s EB66® cell line.

New Hopes For Rheumatic Fever Vaccination
Monday, March 23, 2015
Progress is made by a new initiative funded by CANVAS.

A Vaccine Against Placental Malaria Made with ExpreS2
Saturday, March 21, 2015
ExpreS2ion Biotechnologies’ protein expression technology is ready to start human tests in Germany and Benin.

Emergent Signs Agreements with Oxford University, GSK, and NIAID
Friday, March 20, 2015
200L scale production leverages Emergent's unique expertise and capabilities in MVA-based vaccine product development and manufacturing.

Strengthening the Immune System’s Fight Against Brain Cancer
Friday, March 20, 2015
NIH-funded research suggests novel way to improve vaccine efficacy in brain tumors.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 1239
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters